Última revisão: 22 Set 2020
Última atualização: 30 Out 2018

Resumo

Definição

História e exame físico

Principais fatores de diagnóstico

  • número de cigarros por dia
  • tempo até o primeiro cigarro (TTFC) ≤30 minutos ou >30 minutos
  • abuso de múltiplas substâncias
  • usuário de produtos do tabaco sem combustão
  • transtorno convulsivo
  • gestação ou amamentação

Outros fatores de diagnóstico

  • história de depressão
  • história de esquizofrenia
  • hipertensão
  • doença cardíaca instável
  • arritmia ventricular
  • asma
  • distúrbio da articulação temporomandibular ou problema dentário

Fatores de risco

  • fumante
  • usuário de produtos do tabaco sem combustão

Exames diagnósticos

Algoritmo de tratamento

Colaboradores

Chairman

Pulmonary Department

Director

Pulmonary Education and Rehabilitation

Cleveland Clinic

Weston

FL

Divulgações

FFR has done research, consulting, and speaking for Boehringer Ingelheim, Shire, CSL Behring, and Grifol.

Fellow

Pulmonary medicine/Critical Care

Cleveland Clinic

Weston

FL

Divulgações

FH declares that he has no competing interests.

Dr Franck F. Rahaghi and Dr Felix Hernandez would like to gratefully acknowledge Dr Jose Gonzalez and Dr Theodore W. Marcy, previous contributors to this topic. JG and TWM declare that they have no competing interests.

Colegas revisoresMOSTRAR TODOS

Professor and Chair

Department of Family Medicine

Associate Dean for Faculty Affairs and Development

College of Human Medicine

Michigan State University

East Lansing

MI

Divulgações

WW declares that he has no competing interests.

Medical Director

Tobacco Cessation and Prevention

Providence St. Vincent Hospital and Medical Center

Portland

OR

Divulgações

CJB declares that he has no competing interests.

Department of Family Medicine

National Taiwan University Hospital

Taipei

Taiwan

Divulgações

FRG received a grant from Pfizer, the manufacturer of varenicline, for one of the 3rd phase clinical trials of varenicline. FRG has also been reimbursed by Pfizer, Novartis (the manufacturer of nicotine patch), and GSK (the manufacturer of bupropion SR and nicotine lozenge), for attending conferences, and receiving fees for giving speeches on smoking cessation.

O uso deste conteúdo está sujeito aos nossos avisos legais